SDIC
ALXN

South Dakota Investment Council’s Alexion Pharmaceuticals ALXN Stock Holding History

South Dakota Investment Council’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,358
Closed -$1.9M – 592
2021
Q2 		$1.9M Sell
10,358
-111,350
-91% -$19.1M 0.03% 356
2021
Q1 		$18.6M Buy
121,708
+105,496
+651% +$16.3M 0.31% 73
2020
Q4 		$2.53M Sell
16,212
-1,200
-7% -$154K 0.05% 306
2020
Q3 		$1.99M Sell
17,412
-3,570
-17% -$385K 0.04% 307
2020
Q2 		$2.35M Hold
20,982
– – 0.05% 270
2020
Q1 		$1.88M Buy
20,982
+2,512
+14% +$247K 0.05% 268
2019
Q4 		$2M Sell
18,470
-4,290
-19% -$459K 0.04% 315
2019
Q3 		$2.23M Sell
22,760
-29,250
-56% -$3.3M 0.04% 325
2019
Q2 		$6.81M Buy
52,010
+3,780
+8% +$487K 0.14% 138
2019
Q1 		$6.52M Buy
48,230
+8,430
+21% +$1.05M 0.14% 142
2018
Q4 		$3.88M Buy
39,800
+33,400
+522% +$3.95M 0.1% 176
2018
Q3 		$890K Sell
6,400
-700
-10% -$87.8K 0.02% 432
2018
Q2 		$881K Buy
+7,100
New +$830K 0.02% 449
2017
Q3 		– Sell
-9,200
Closed -$1.12M – 618
2017
Q2 		$1.12M Hold
9,200
– – 0.02% 398
2017
Q1 		$1.11M Buy
+9,200
New +$1.19M 0.02% 397

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

South Dakota Investment Council's ALXN Position: Q3 2021 in Review

South Dakota Investment Council sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 10,358 shares — an estimated $1.9M sold.

South Dakota Investment Council first reported a position in ALXN in Q1 2017 and held it in 15 quarters. The position peaked at $18.6M in Q1 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • South Dakota Investment Council reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • South Dakota Investment Council sold 10,358 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.9M.
  • South Dakota Investment Council first reported a position in Alexion Pharmaceuticals in Q1 2017 and held it in 15 quarters.
  • South Dakota Investment Council's Alexion Pharmaceuticals position peaked at $18.6M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on South Dakota Investment Council's 13F filing for Q3 2021, filed 9 Nov 2021.